Target intelligence / Profile preview

Cell-matrix interfaces

Molecular classification
Other (multi-molecular complex/interface, not a single receptor or enzyme), Matrix receptor (e.g., integrins), Adhesion complex (e.g., focal adhesions, hemidesmosomes)
01

Overview

The cell-matrix interface encompasses the dynamic structural and functional regions where cells physically and chemically interact with the extracellular matrix (ECM)[1][3][5]. This interface involves matrix receptors such as integrins and associated adhesive proteins that connect the cell cytoskeleton to ECM proteins like collagen and fibronectin[1][5]. The interface enables cells to adhere, migrate, sense mechanical and biochemical signals, and direct structural and functional behaviors essential for development, tissue repair, and disease processes[2][3][4][6][7]. While not a single drug target, the molecules composing these interfaces—particularly integrins and adhesion complexes—are clinically relevant in conditions such as cancer metastasis, fibrosis, and vascular diseases[2][4][5][7]. The term “cell-matrix interface” is structurally and functionally descriptive, rather than denominating an individual molecule, and is best interpreted as referring to sites of interaction between cells and their ECM via receptor complexes (e.g., integrins), scaffolding proteins, and associated signaling pathways.

Other names
cell–extracellular matrix interfacecell–matrix junctioncell–ECM contact sitesfocal adhesion
02

Mechanism of action

Inhibition of integrin-ligand binding, blocking cell adhesion or migration; Modulation of matrix assembly or degradation (e.g., MMP inhibitors)

03

Biological functions

Cell adhesionSignal transductionCell migration and polarizationCell differentiationMechanotransduction (response to physical/chemical cues)Tissue morphogenesis and repair
04

Disease associations

Cancer (especially metastasis via altered cell-matrix interactions)Inflammation (matrix remodeling accompanies chronic inflammation)Fibrosis (dysregulated matrix turnover)Wound healing disordersCardiovascular disease (vascular cell migration and remodeling)
05

Safety considerations

Broad tissue effects due to ubiquity of cell-matrix interactionsPotential for impaired wound healing, tissue regeneration, or immune reactionsOff-target effects when modulating matrix turnover or adhesion complexes
06

Interacting drugs

Drugs targeting integrins (e.g., natalizumab)

1 more in the full profile.

07

Biomarkers

Expression levels of integrins (e.g., αvβ3, α5β1)Matrix protein turnover (collagen, fibronectin, laminin)Focal adhesion proteins (talin, vinculin, FAK)

Beyond the preview

Go deeper on Cell-matrix interfaces.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell-matrix interfaces.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call